Interleukin-11

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

adipogenesis inhibitory factor (AGIF); IL-11; Megakaryocyte colony stimulating factor (MEG-CSF); Plasmacytoma stimulator activity; T1154 mitogenic activity; T1154 mitogenic activity.

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Interleukins (from Latin/Greek inter = between; leukos = white; kinein = to move) are a group of endogenous, short-chain regulatory proteins (cytokines) of the immune system (Interleukin-1 to Interleukin-38). Interleukins are mediators for induction, course and control of T-cell-mediated cytotoxic immune reactions as well as B-cell activation (antibody production). Interleukin-11 (analogous to TGF-beta and Interleukin-10) has an anti-inflammatory effect by preventing excessive inflammatory reactions. The cytokine is therefore important for the balance of the immune system.

Interleukin-11 is encoded by the interleukin-11 gene, a gene located on chromosome 19. Interleukin-11 is formed by stromal fibroblasts of the bone marrow and mesenchymal cells. The synthesis is induced by interleukin-1alpha.

Like interleukin-6, interleukin-11 docks to the Gp130 receptor protein (Gp 130 was initially described as "interleukin-6 transducer chain" or "interleukin-6 signal transducer"; the number 130 stands for its molecular mass of 130 kDa). Both cytokines activate the same "downstream signaling pathways" with activation of the MAPK and the Jak/STAT cascade.

General informationThis section has been translated automatically.

The pleiotropic physiological function of interleukin-6 ranges from influencing embryonic development, tissue homeostasis of neuronal development to T-cell differentiation. Furthermore, interleukin-11 promotes the primary and secondary immune response and modulates antigen-specific antibody reactions. It often acts synergistically with other cytokines (e.g. interleukin -1). Interleukin-11 stimulates, synergistically with interleukin-3 and other cytokines, the colony formation of megakaryocytes and erythropoietic stem cells.

Polymorphisms of IL11RA are associated with thyroid carcinoma in the Korean population.

The interleukin-11 receptor is increasingly expressed in CD38-positive myeloma and Hodgkin's lymphoma, breast cancer.

Both interleukin-11 and IL11RA play a role in the progression of endometrial cancer and colorectal adenocarcinoma (C19).

The interleukin-alpha-subunit of the interleukin-11-receptor showed anti-apoptotic effects in human colon epithelia.

LiteratureThis section has been translated automatically.

  1. Chérel M et al (1995) Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11 Blood 86: 2534-2540
  2. Cork BA et al (2002) Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod 8:841-848.
  3. Garbers C et al (2013) Interleukin-6 and interleukin-11: same same same butdifferent. Biol Chem 394:1145-1161.
  4. Fourcin M et al (1994) Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J Immunol 24:277-280.
  5. Hu JP et al (1993) Effects of interleukin-11 onthe proliferation and cell cycle status of myeloid leukemic cells. Blood 81(:1586-1592.

Authors

Last updated on: 29.10.2020